Real-world outcomes in patients with brain metastases secondary to melanoma treated with nivolumab/relatlimab. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results